TP53 and thyroid gland carcinoma: And gradient NVP-BEZ235 (0, 50, 100, 200, 500 and 1000 nM) application significantly slowed the growth of both p53 wild type and mutant thyroid cancer cells cultured for 48 h, showing a dose-dependent inhibitory effect (Figure 2B).